2-219539619-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024536.6(CHPF):c.2092G>A(p.Glu698Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,613,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024536.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHPF | NM_024536.6 | c.2092G>A | p.Glu698Lys | missense_variant | 4/4 | ENST00000243776.11 | NP_078812.3 | |
CHPF | NM_001195731.2 | c.1606G>A | p.Glu536Lys | missense_variant | 4/4 | NP_001182660.2 | ||
CHPF | XM_011511838.4 | c.1219G>A | p.Glu407Lys | missense_variant | 3/3 | XP_011510140.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHPF | ENST00000243776.11 | c.2092G>A | p.Glu698Lys | missense_variant | 4/4 | 1 | NM_024536.6 | ENSP00000243776 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152266Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000164 AC: 41AN: 249852Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135322
GnomAD4 exome AF: 0.000216 AC: 315AN: 1461554Hom.: 1 Cov.: 30 AF XY: 0.000249 AC XY: 181AN XY: 727118
GnomAD4 genome AF: 0.000249 AC: 38AN: 152384Hom.: 0 Cov.: 34 AF XY: 0.000268 AC XY: 20AN XY: 74518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.2092G>A (p.E698K) alteration is located in exon 4 (coding exon 4) of the CHPF gene. This alteration results from a G to A substitution at nucleotide position 2092, causing the glutamic acid (E) at amino acid position 698 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at